|
|
|||||
|
|
|
||||
|
|
|||||
|
text
|
|
||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|
|
|
|
|
|
Geeta Nargund – President
Rene Frydman – Chairman
Bart Fauser – Head of Scientific Committee
Svend Lindenberg – IVM
Stuart Campbell – Ultrasound
Osama Kato – Natural Cycle IVF
Masashige Kuwayama – Embryology
Willem Ombelet – Affordability & Developing Countries
Advisors:
Louise Brinton – Follow-up studies & Safety of Drugs
Karl Nygren – Safety and Regulation
Milton Leong – IVM Registry
Stephen Hillier – Reproductive Physiology
|